At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...
The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its ...
The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Vyjuvek for the treatment of wounds in patients with dystrophic epidermolysis bullosa, ...
Eisai (ESAIY) and Biogen (BIIB) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, ...